544629 — Ravelcare Income Statement
0.000.00%
- IN₹1.07bn
- IN₹1.05bn
- IN₹249.79m
- 44
- 26
- 58
- 36
Annual income statement for Ravelcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 34.9 | 221 | 250 |
| Cost of Revenue | |||
| Gross Profit | 27.3 | 156 | 198 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Depreciation and Amortization | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 29.9 | 155 | 182 |
| Operating Profit | 5.06 | 66.2 | 67.4 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 5.06 | 68.1 | 70.4 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 4.15 | 50.2 | 52.6 |
| Net Income Before Extraordinary Items | |||
| Net Income | 4.15 | 50.2 | 52.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 4.15 | 50.2 | 52.6 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 0.605 | 7.32 | 7.66 |